← Eichor
Study identifier: NCT04681573 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Comparison of Two sTRAtegies For the Non-Invasive Diagnosis of advanCed Liver Fibrosis in NAFLD

Condition: NAFLD  ·  Sponsor: University Hospital, Angers

PhaseNA
Planned participants1045
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

NAFLD, closely linked to overweight and insulin resistance, has reached 25% prevalence worldwide. Advanced liver fibrosis(ALF) must be accurately diagnosed in NAFLD because it defines a subgroup of patients with impaired prognosis, and these patients need a specific management to prevent the occurrence of liver-related complication. Relatively few NAFLD patients develop ALF and it is a challenge for physicians to identify them. Liver biopsy is the reference for liver fibrosis evaluation but this invasive procedure cannot be first-line used in NAFLD. Non-invasive diagnosis of liver fibrosis is now available, especially liver stiffness measurement (LSM) with Fibroscan and blood fibrosis tests. However, Fibroscan is a costly device available only in few specialized centres with thus poor accessibility in face of the large NAFLD population. Blood fibrosis tests can be performed by every physician and are distinguished as "complex" or "simple". Because they include specialized biomarkers, complex blood fibrosis tests are accurate for the diagnosis of ALF but they are quite expensive and not reimbursed, with therefore limited use in clinical practice. Simple blood fibrosis tests have the advantage to include cheap and easy-to-obtain biomarkers with simple calculation thanks to free websites or smartphone applications. Simple blood fibrosis tests are globally less accurate than complex blood fibrosis tests or Fibroscan but, used with a high-sensitivity cut-off, they have the high i…

This description comes directly from the study's public registry record.

Talk to the study team

Jérôme Boursier, MD-PHD  ·  +33241353410  ·  jeboursier@chu-angers.fr

Marc de Saint Loup  ·  +33241357812  ·  madesaintloup@chu-angers.fr

Always discuss trial participation with your own doctor first.

Locations (20)

University Hospital of AngersAngers, FranceRecruiting
University Hospital of BesançonBesançon, FranceNot Yet Recruiting
Avicenne Hospital (Greater Paris University Hospitals)Bobigny, FranceNot Yet Recruiting
University Hospital of DijonDijon, FranceRecruiting
Departemental Hospital Center of VendéeLa Roche-sur-Yon, FranceRecruiting
University Hospital of GrenobleLa Tronche, FranceActive Not Recruiting
University Hospital of LilleLille, FranceActive Not Recruiting
University Hospital of LimogesLimoges, FranceActive Not Recruiting
Edouard Herriot HospitalLyon, FranceNot Yet Recruiting
La Croix Rousse HospitalLyon, FranceRecruiting
Saint Joseph HospitalMarseille, FranceNot Yet Recruiting
University Hospital of MontpellierMontpellier, FranceRecruiting

+ 8 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04681573